Payload Information
General Information of This Payload
Payload ID | PAY0TZRTO |
|||||
---|---|---|---|---|---|---|
Name | PM050489 |
|||||
Synonyms |
PM050489; SCHEMBL12895632; HY-N10558; CS-0611026
Click to Show/Hide
|
|||||
Target(s) | Microtubule (MT) | |||||
Structure |
![]() |
|||||
Formula | C31H44ClN3O7 |
|||||
Isosmiles | C[C@@H](/C=C(\C)/C=C\C=C/C(=O)N[C@H](C(=O)N/C=C\C[C@H](C/C=C(\C)/Cl)OC(=O)N)C(C)(C)C)[C@@H]1CC=C(C(=O)O1)OC |
|||||
PubChem CID | ||||||
InChI |
InChI=1S/C31H44ClN3O7/c1-20(19-21(2)24-16-17-25(40-7)29(38)42-24)11-8-9-13-26(36)35-27(31(4,5)6)28(37)34-18-10-12-23(41-30(33)39)15-14-22(3)32/h8-11,13-14,17-19,21,23-24,27H,12,15-16H2,1-7H3,(H2,33,39)(H,34,37)(H,35,36)/b11-8-,13-9-,18-10-,20-19+,22-14+/t21-,23+,24-,27+/m0/s1
|
|||||
InChIKey |
KRJDJEJEUDVRKZ-HUSNLYBVSA-N
|
|||||
IUPAC Name |
[(1Z,4R,6E)-7-chloro-1-[[(2S)-2-[[(2Z,4Z,6E,8S)-8-[(2S)-5-methoxy-6-oxo-2,3-dihydropyran-2-yl]-6-methylnona-2,4,6-trienoyl]amino]-3,3-dimethylbutanoyl]amino]octa-1,6-dien-4-yl] carbamate
|
|||||
Pharmaceutical Properties | Molecule Weight |
606.1 |
Polar area |
146 |
||
Complexity |
1150 |
xlogp Value |
6.1 |
|||
Heavy Count |
42 |
Rot Bonds |
16 |
|||
Hbond acc |
7 |
Hbond Donor |
3 |
The activity data of This Payload
Standard Type | Value | Units | Cell line | Disease Model | Cell line ID | Reference |
---|---|---|---|---|---|---|
Half Maximal Inhibitory Concentration (IC50) | 0.04 | nM |
NB-4 cells
|
Promyelocytic leukemia
|
[1] | |
Half Maximal Inhibitory Concentration (IC50) | 0.09 | nM |
U-937 cells
|
Adult acute monocytic leukemia
|
[1] | |
Half Maximal Inhibitory Concentration (IC50) | 0.14 | nM |
RPMI-8226 cells
|
Plasma cell myeloma
|
[1] | |
Half Maximal Inhibitory Concentration (IC50) | 0.36 | nM |
Raji cells
|
EBV-related Burkitt lymphoma
|
[1] | |
Half Maximal Inhibitory Concentration (IC50) | 0.4 | nM |
HT-1080 cells (FAP expression)
|
Fibrosarcoma
|
[1] |
Each Antibody-drug Conjugate Related to This Payload
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.